Carlos Velazquez, University of Alberta

Research

Drug Design Forkhead Box Proteins Foxm1 Medicinal Chemistry Molecular Modeling Ovarian Cancer Transcription Transcription Factors

Latest funding

FOXM1 protein-targeted degradation and its potential role in the treatment of ovarian cancer: a medicinal chemistry approach
CIHR · 2022 · Nominated PI
$730,576
Discovery and Development of Brain-Sparing Inhibitors of Succinyl-CoA:3-Ketoacid CoA Transferase
CIHR · 2021 · Co-investigator
$898,876
Pharmacological Characterization of eNOS-based Platelet Subpopulations
CIHR · 2018 · Co-investigator
$623,475

All 4 grants and awards

FOXM1 protein-targeted degradation and its potential role in the treatment of ovarian cancer: a medicinal chemistry approach

Nominated PICIHR2022Project Grant

Principal investigators: Velazquez, Carlos A

Keywords: Drug Design; Forkhead Box Proteins; Foxm1; Medicinal Chemistry; Molecular Modeling; Ovarian Cancer; Transcription; Transcription Factors

$730,576

Discovery and Development of Brain-Sparing Inhibitors of Succinyl-CoA:3-Ketoacid CoA Transferase

Co-investigatorCIHR2021Project Grant

Principal investigators: Ussher, John R

Keywords: Chemical Synthesis; Ketone Body Oxidation; Molecular Modeling; Preclinical Drug Development; Structure-Guided Drug Design; Succinyl Coa:3-Ketoacid Coa Transferase

$898,876

Pharmacological Characterization of eNOS-based Platelet Subpopulations

Co-investigatorCIHR2018Project Grant

Principal investigators: Jurasz, Paul K

Keywords: Anti-Platelet Drugs; Endothelial Nitric Oxide Synthase; Flow Cytometry; Matrix Metalloproteinases; Myocardial Infarction; Nitric Oxide; Pharmacology; Platelet Function Testing; Platelets; Prognostic Biomarkers

$623,475

Bone-Targeting Peptide & Protein Hormones for Endocrine Bone Disorders

Co-investigatorCIHR2016Project Grant

Principal investigators: Doschak, Michael R

Keywords: Biologic Drugs; Bisphosphonate Drugs; Bone; Bone Drug Delivery; Calcitonin; Micro-Computed Tomography Imaging; Osteoporosis; Parathyroid Hormone; Peptide Hormone Drugs; Transdermal Microneedle Patch

$367,200

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2022

Subject: Prospective PhD student: Drug Design Dear Professor Velazquez, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on drug design connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "FOXM1 protein-targeted degradation and its potential role in the treatment of ovarian cancer: a medicinal chemistry approach" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]